↓ Skip to main content

Immunogenicity and clinical features relating to BNT162b2 messenger RNA COVID-19 vaccine, Ad26.COV2.S and ChAdOx1 adenoviral vector COVID-19 vaccines: a systematic review of non-interventional studies

Overview of attention for article published in Future Journal of Pharmaceutical Sciences, March 2022
Altmetric Badge

Mentioned by

twitter
3 X users

Readers on

mendeley
39 Mendeley
Title
Immunogenicity and clinical features relating to BNT162b2 messenger RNA COVID-19 vaccine, Ad26.COV2.S and ChAdOx1 adenoviral vector COVID-19 vaccines: a systematic review of non-interventional studies
Published in
Future Journal of Pharmaceutical Sciences, March 2022
DOI 10.1186/s43094-022-00409-5
Pubmed ID
Authors

Chinonyerem O. Iheanacho, Uchenna I. H. Eze

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 39 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 15%
Student > Master 3 8%
Researcher 3 8%
Other 2 5%
Professor 2 5%
Other 3 8%
Unknown 20 51%
Readers by discipline Count As %
Medicine and Dentistry 9 23%
Nursing and Health Professions 5 13%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Biochemistry, Genetics and Molecular Biology 1 3%
Decision Sciences 1 3%
Other 1 3%
Unknown 20 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 January 2024.
All research outputs
#17,301,727
of 25,392,582 outputs
Outputs from Future Journal of Pharmaceutical Sciences
#40
of 96 outputs
Outputs of similar age
#268,980
of 445,813 outputs
Outputs of similar age from Future Journal of Pharmaceutical Sciences
#1
of 1 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 96 research outputs from this source. They receive a mean Attention Score of 3.5. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,813 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them